Safety and efficacy of MT-601 in relapsed or refractory (r/r) Hodgkin lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Haitham Abdelhakim, Geoffrey Shouse, Manali Kamdar, Priyanka Pophali, Samuel Yamshon, Luke Mountjoy, Aravind Ramakrishnan, Ian Flinn, Akiva Diamond, Margaret Gilbert, Maria-Bernadette Madel, Laura Angelo, Hettie Stein, Deb Chapman, Patricia Allison, John Gutheil, Teresa Melink, Susie Bergman, Mary Newman, Helen Heslop, Malcolm Brenner, Premal Lulla, Monic Stuart, Juan Vera
Institutions: University of Kansas Medical Center, City Of Hope National Medical Center, University of Colorado Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Weill Cornell Medicine, Colorado Blood Cancer Institute, St David's Medical Center, Tennessee Oncology, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, Houston Methodist, Texas Children's Hospital
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108478449